Litigation

New Bill Could Be a Game-Changer for Mulit District Litigations and Class Actions

The Fairness in Class Action Litigation Act of 2017, introduced in the U.S. House and approved by the Judiciary Committee last week, proposes far-reaching changes to the rules governing multidistrict litigations (MDLs), removals and class actions. Sponsored by the chairman of the House Judiciary Committee, Rep. Bob Goodlatte (R-Va), the bill’s stated purpose is to …


Questions About EPA-Monsanto Collusion Raised in Cancer Lawsuits

Now it’s getting interesting. A new court filing made on behalf of dozens of people claiming Monsanto Co.’s Roundup herbicide gave them cancer includes information about alleged efforts within the Environmental Protection Agency to protect Monsanto’s interests and unfairly aid the agrichemical industry. The filing, made late Friday by plaintiff’s attorneys, includes what the attorneys represent …


DuPont Settles Lawsuits Over Leak of Chemical Used to Make Teflon

Arathy S Nair DuPont and Chemours Co have agreed to pay $671 million in cash to settle thousands of lawsuits involving a leak of a toxic chemical used to make Teflon, the companies said on Monday. Shares of Chemours jumped 13 percent. The company said it would pay half of the settlement, although liability for litigation connected with the chemical was passed onto it when DuPont spun it off in …


What’s Behind the Rise in Shareholder Class Actions?

There’s been several high profile class actions launched by unhappy shareholders against the companies they invest in (otherwise known as securities class actions) lately in Australia. The common theme is a claim these companies have not been straight with investors, issuing falsely optimistic information or concealing negative information. If it’s proved to be true, this sort of conduct does …


For the First Time, Court Requires “litigation Funders” to Be Disclosed — but Only in Class Actions

On January 26, the U.S. District Court for the Northern District of California became the first court to mandate disclosure of litigation funding that parties in class actions receive from outside sources, under a revision to the court’s standing order applicable to all cases. The rule provides that “in any proposed class, collective or representative action, the required disclosure includes …


Representative Goodlatte Introduces Litigation Reform Bill

Congressman Bob Goodlatte (R-Va.), Chairman of the House Judiciary Committee, released the following statement upon the introduction of the Fairness in Class Action Litigation Act of 2017 (H.R. 985): “Due to the complexity and costs associated with our legal system, a lawsuit has become a dirty …


Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement of Revance Therapeutics, Inc. Securities Litigation

SUMMARY NOTICE OF PROPOSED SETTLEMENT OF CLASS ACTION TO: ALL PERSONS OR ENTITIES (“PERSONS”) THAT PURCHASED OR OTHERWISE ACQUIRED REVANCE THERAPEUTICS, INC. (“REVANCE” OR THE “COMPANY”) COMMON STOCK DURING THE PERIOD BEGINNING ON JUNE 19, 2014 AND ENDING ON MAY 1, 2015, AND PURSUANT AND/OR TRACEABLE TO THE REGISTRATION STATEMENT AND PROSPECTUS FOR THE COMPANY’S JUNE 19, 2014 PUBLIC OFFERING …


IMPORTANT STEMLINE THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Lawsuit Has Been Filed in the Southern District of New York Against Stemline Therapeutics, Inc.

NEW YORK, Feb. 07, 2017 — Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York against Stemline Therapeutics, Inc. (“Stemline” or the “Company”) (NASDAQ:STML) on behalf of investors that acquired Stemline securities: (1) pursuant and/or traceable to Stemline’s secondary public …


SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline – March 13, 2017

Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Novo Nordisk A/S (“Novo” or the “Company”) (NYSE:NVO) and certain of its officers, and is on behalf of a class consisting of all persons or entities who purchased Novo American Depositary Receipts (“ADR”) between April 30, 2015 and October …


U.S. Supreme Court Agrees to Review Mandatory Arbitration Agreements With Class Action Waivers: Hinshaw & Culbertson LLP – National Law Firm | 525 Attorneys

U.S. Supreme Court Agrees to Review Mandatory Arbitration Agreements with Class Action Waivers February 1, 2017 Human Resource Executive Hinshaw attorney Aimee Delaney spoke to Tom Starner of Human Resource Executive about the recent decision by the U.S. Supreme Court to review the legality of class action waivers in labor-based arbitration agreements. Currently, some class and collective …